Contacto
Contact
Acceso clientes
Client access
R&D+i
SPECIALISTS
PATIENTS
ABOUT US
Inicio
Home
map
Imprimir
Print
Enviar
Send
map
Site Map
Inicio
About us
Team
History
Objectives
Location
Patients
Embryo
Embryo biopsy
PGD of monogenic diseases
Chromosomal PGD
Pregnancy
Rapid prenatal diagnosis
Prenatal chromosomal diagnosis CGH arrays
Prenatal diagnosis of monogenic diseases
Chromosomal analysis in spontaneous abortions
Adults and children
How to access our services
Specialists
Preimplantational diagnosis
Embryo biopsy
Informative study in carriers of structural anomalies
PGD in carriers of structural anomalies
PGD in 5 or 9 cromosomal aneuploidies by fish
PGD in 24 cromosomal aneuploidies by CGH array
PGD of monogenic diseases
Chromosomal PGD
Prenatal diagnosis
Prenatal diagnosis
Rapid prenatal diagnosis by QF-PCR
Rapid prenatal diagnosis by means of BoBs
CGH Array
Prenatal diagnosis of monogenic diseases
Chromosomal analyses in spontaneous abortions
Genetic diagnosis in adults and postnatal
ERA
GIC
5-Chromosome spermatozoid FISH
Reproductive genomics
Contact
R&D+i
Research
Product development
Projects financed
Patents
Collaborations and consortia
Professional access
Copyright 2012
Mapa del web
|
Contacto
|
Nota legal
The NACE Plus test is designed to rule out the presence of the most frequent chromosomal alterations in single pregnancies without putting the pregnancy at risk.
It is especially suitable for women with a high risk of chromosomal abnormalities after screening in the 1st trimester*, with previous Down syndrome pregnancies or where suspicious alterations have been detected in scans.
Given the characteristics and safety of the test, it can be used by women of any age in the following situations:
Where there has been test-tube fertilisation and, particularly, for pregnancies using donated ova.
Independent of body mass or ethnic group.
Site Map
|
Contact
|
legal
Mapa del web
|
Contacto
|
Nota legal
Site Map
|
Contact
|
Legal